Combined FDG and [F-18]fluoride whole-body PET: A feasible two-in-one approach to cancer imaging?

Radiology

Volumn 209, Issue 1, 1998, Pages 253-258

  Hoegerle, Stefan ^a   Juengling, Freimut ^a   Otte, Andreas ^a   Altehoefer, Carsten ^a   Moser, Ernst A ^a   Nitzsche, Egbert U ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Emission CT (ECT), technology; Fluorine; Neoplasms, emission CT (ECT)

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE CANCER; TESTIS CANCER; THYROID CANCER;

EID: 0031709648     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.209.1.9769840     Document Type: Article

References (23)

1. Hawkins RA, Hoh C, Dahlbom M, et al. PET cancer evaluations with FDG. J Nucl Med 1991; 32:1555-1558.
2. Hawkins RA, Hoh C, Glaspy J, et al. The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 1992; 22:268-284.
3. Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK. Whole body PET: physiological and artefactual fluorodeoxyglucose accumulations. J Nucl Med 1996; 37:441-446.
4. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. Anatometabolic tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993; 34:1190-1197.
5. Pellizari CA, Chen GTY, Speibring DR, Weichselbaum RR, Chen CT. Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assist Tomogr 1989; 13:20-26.
6. Wieland BW, Bida GT, Padgett HC, Hendry GO. Current status of CTI target systems for the production of PET radiopharmaceuticals. In: RuIh TJ, ed. Proceedings of the Third Workshop on Targetry and Target Chemistry. Vancouver, British Columbia, Canada: Triumf, 1990; 34-48.
7. Mulholland GK. Simple rapid hydrolysis of acetyl protecting groups in FDG synthesis using cation exchange resins. Nucl Med Biol 1995; 22:19-23.
8. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35:1308-1312.
9. Stomper PC. Cancer imaging manual. Philadelphia, Pa: Lippincott, 1993; 51-60.
10. Alazraki N. Radionuclide techniques. In: Resnick D, ed. Bone and joint imaging. Philadelphia, Pa: Saunders, 1996; 141-150.
11. Fleiss JL. Estimating the magnitude of error. In: Fleiss JL, ed. Statistical methods for rates and proportions. New York, NY: Wiley, 1973; 143-147.
12. Tahara T, Ichiya Y, Kuwabara Y, et al. High [18F]fluorodeoxyglucose uptake in abdominal abscess: a PET study. J Comput Assist Tomogr 1989; 13:829-831.
13. Galasko CS. The significance of occult metastases, detected by skeletal scintigraphy, in patients with apparently early mammary carcinoma. Br J Surg 1975; 62:694-696.
14. Hawkins RA, Choi Y, Huang SC, et al. Evaluation of the skeletal kinetics of fluorine-18Fluoride ion with PET. J Nucl Med 1992; 33:633-642.
15. Hoh CK, Hawkins RA, Dahlboom M, et al. Whole body skeletal imaging with (18F)fluoride ion and PET. J Comput Assist Tomogr 1993; 17:34-41.
16. Schiepers C, Broos P, Nuyts J, Mortelmans L, Verbruggen A, De Roo M. Positron emission tomography using 18-fluoride for the evaluation of femoral head osteonecrosis. Eur J Nucl Med 1994; 21:762-767.
17. Messa C, Goodman WG, Hoh CK, et al. Bone metabolic activity measured with positron emission tomography and (18F)fluoride ion in renal osteodystrophy. J Clin Endocrinol Metab 1993; 77:949-955.
18. Berding G, Burchert W, van den Hoff J, et al. Evaluation of the incorporation of bone grafts used in maxillofacial surgery with (18F)fluoride ion and dynamic positron emission tomography. Eur J Nucl Med 1995; 22:1133-1140.
19. Wooton R, Dore C. The single-passage extraction of 18Fluoride in rabbit bone. Clin Phys Physiol Meas 1986; 7:333-343.
20. van Schelwen WD, Pauwels EK. The flare phenomenon: far from air and square. Eur J Nucl Med 1994; 21:377-380.
21. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. International Commission on Radiological Protection publication no. 53. Oxford, England: Pergamon, 1988.
22. Johansson E, Mattsson S, Nosslin B, Leide-Svegborn S. Effective dose of radiopharmaceuticals. Eur J Nucl Med 1992; 19:933-938.
23. Radiation protection regulation. Federal Republic of Germany government paper. Cologne, Germany: Bundesanzeiger, 1992; 37-118. [German]